Management of newly diagnosed HIV infectionHAMMER, Scott M.The New England journal of medicine. 2005, Vol 353, Num 16, pp 1702-1710, issn 0028-4793, 9 p.Article

Host determinants in HIV infection and disease. Part 1 : Cellular and humoral immune responsesHOGAN, Christine M; HAMMER, Scott M.Annals of internal medicine. 2001, Vol 134, Num 9, pp 761-776, issn 0003-4819, 1Article

Host determinants in HIV infection and disease. Part 2 : Genetic factors and implications for antiretroviral therapeuticsHOGAN, Christine M; HAMMER, Scott M.Annals of internal medicine. 2001, Vol 134, Num 10, pp 978-996, issn 0003-4819Article

Antiretroviral Treatment of Adult HIV Infection : 2008 Recommendations of the International AIDS Society-USA PanelHAMMER, Scott M; ERON, Joseph J; JACOBSEN, Donna M et al.JAMA, the journal of the American Medical Association. 2008, Vol 300, Num 5, pp 555-570, issn 0098-7484, 16 p.Article

Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudineDYKES, Carrie; NAJJAR, Joe; BOSCH, Ronald J et al.The Journal of infectious diseases. 2004, Vol 189, Num 6, pp 1091-1096, issn 0022-1899, 6 p.Article

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: Issues involving surrogate end points in phase 3 trialsGILBERT, Peter B; DEGRUTTOLA, Victor G; HUDGENS, Michael G et al.The Journal of infectious diseases. 2003, Vol 188, Num 2, pp 179-193, issn 0022-1899, 15 p.Article

Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliterDEMETER, Lisa M; BOSCH, Ronald J; FISCHL, Margaret A et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 6, pp 2089-2094, issn 0095-1137Article

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infectionALBRECHT, Mary A; BOSCH, Ronald J; HAMMER, Scott M et al.The New England journal of medicine. 2001, Vol 345, Num 6, pp 398-407, issn 0028-4793Article

Low Bone Mass and High Bone Turnover in Postmenopausal Human Immunodeficiency Virus-Infected WomenYIN, Michael T; MCMAHON, Don J; SHANE, Elizabeth et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 2, pp 620-629, issn 0021-972X, 10 p.Article

Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118)GRIPSHOVER, Barbara M; RIBAUDO, Heather; SANTANA, Jorge et al.Antiviral therapy (London). 2006, Vol 11, Num 5, pp 619-623, issn 1359-6535, 5 p.Article

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA panelHIRSCH, Martin S; BRUN-VEZINET, Francoise; MELLORS, John W et al.Clinical infectious diseases. 2003, Vol 37, Num 1, pp 113-128, issn 1058-4838, 16 p.Article

Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA panelYENI, Patrick G; HAMMER, Scott M; MONTANER, Julio S. G et al.JAMA, the journal of the American Medical Association. 2002, Vol 288, Num 2, pp 222-235, issn 0098-7484Article

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patientsFALLOON, Judith; AIT-KHALED, Mounir; TORRES, Ramon et al.AIDS (London). 2002, Vol 16, Num 3, pp 387-396, issn 0269-9370Article

Virologic and regimen termination surrogate end points in AIDS Clinical TrialsGILBERT, Peter B; DEGRUTTOLA, Victor; HAMMER, Scott M et al.JAMA, the journal of the American Medical Association. 2001, Vol 285, Num 6, pp 777-784, issn 0098-7484Article

Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like ParticlesGOEPFERT, Paul A; ELIZAGA, Marnie L; KEEFER, Michael C et al.The Journal of infectious diseases. 2014, Vol 210, Num 1, pp 99-110, issn 0022-1899, 12 p.Article

Transmitted Drug Resistance Among Antiretroviral-Naive Patients with Established HIV Type 1 Infection in Santo Domingo, Dominican Republic and Review of the Latin American and Caribbean LiteratureMYERS, Julie E; TAYLOR, Barbara S; LIE, Yolanda et al.AIDS research and human retroviruses. 2012, Vol 28, Num 7, pp 667-674, issn 0889-2229, 8 p.Article

Low Frequency Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant Variants Contribute to Failure of Efavirenz-Containing Regimens in Treatment-Experienced PatientsHALVAS, Elias K; WIEGAND, Ann; MELLORS, John W et al.The Journal of infectious diseases. 2010, Vol 201, Num 5, pp 672-680, issn 0022-1899, 9 p.Article

Lessons Drawn From Recent HIV Vaccine Efficacy TrialsFUCHS, Jonathan D; SOBIESZCZYK, Magda E; HAMMER, Scott M et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, issn 1525-4135, S128-S131, SUP2Article

Persistent Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnucleoside Reverse-Transcriptase Inhibitor-Based TherapyCOOVADIA, Ashraf; HUNT, Gillian; HAMMER, Scott M et al.Clinical infectious diseases. 2009, Vol 48, Num 4, pp 462-472, issn 1058-4838, 11 p.Article

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection : 2008 Recommendations of an International AIDS Society-USA PanelHIRSCH, Martin S; GÜNTHARD, Huldrych F; YENI, Patrick G et al.Clinical infectious diseases. 2008, Vol 47, Num 2, pp 266-285, issn 1058-4838, 20 p.Article

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus diseaseFISCHL, Margaret A; RIBAUDO, Heather J; MORSE, Gene D et al.The Journal of infectious diseases. 2003, Vol 188, Num 5, pp 625-634, issn 0022-1899, 10 p.Article

Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapyLATHEY, Janet L; TIERNEY, Camlin; LANDES, Jeff E et al.The Journal of infectious diseases. 2001, Vol 184, Num 11, pp 1402-1411, issn 0022-1899Article

Translational Research Insights From Completed HIV Vaccine Efficacy TrialsTIEU, Hong-Van; ROLLAND, Morgane; HAMMER, Scott M et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, issn 1525-4135, S150-S154, SUP2Article

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society―USA PanelTHOMPSON, Melanie A; ABERG, Judith A; RICHMAN, Douglas D et al.JAMA, the journal of the American Medical Association. 2012, Vol 308, Num 4, pp 387-402, issn 0098-7484, 16 p.Article

Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy TrialsGILBERT, Peter B; BERGER, James O; STABLEIN, Donald et al.The Journal of infectious diseases. 2011, Vol 203, Num 7, pp 969-975, issn 0022-1899, 7 p.Article